Related Experiment Video

Updated: Aug 16, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

[Mechanism of inhibiting the proliferation of prostate cancer by finasteride: a study using cDNA microarray]

Gang Chen1, Jiang Geng, Yuan-fang Zhang

  • 1Department of Urology, Jinshan Hospital, Fudan University, Shanghai 200540, China.

Zhonghua Yi Xue Za Zhi
|August 3, 2005
PubMed
Abstract

Insights

Finasteride inhibits prostate cancer cell proliferation by affecting multiple genes involved in cell metabolism, proliferation, and apoptosis. This study screened 96 genes, identifying 29 differentially expressed genes, offering new insights into finasteride

Area of Science:

  • Molecular biology and oncology
  • Gene expression analysis
  • Prostate cancer research

Context:

  • Prostate cancer remains a significant health concern, necessitating novel therapeutic strategies.
  • Finasteride is known to affect androgen metabolism, a key factor in prostate cancer.
  • Understanding the molecular mechanisms of finasteride's action is crucial for optimizing its use.

Purpose:

  • To identify genes and pathways modulated by finasteride treatment in prostate cancer cells.
  • To screen for differentially expressed genes in LNCaP prostate cancer cells upon finasteride exposure.
  • To elucidate the genetic basis for finasteride's antiproliferative effects.

Summary:

  • Finasteride significantly inhibited the proliferation of LNCaP prostate cancer cells in vitro.
  • A cDNA microarray analysis revealed differential expression of 29 out of 96 screened genes.
  • Key affected genes are involved in cell metabolism, proliferation, apoptosis, and signal transduction (e.g., AKR1B1, PTEN, NKX3.1, PMEPA1, PSA, XRCC2).

Impact:

  • Identifies specific genes and pathways potentially mediating finasteride's anti-cancer effects.
  • Provides a foundation for further research into finasteride as a therapeutic agent for prostate cancer.
  • Suggests that finasteride's efficacy may stem from a coordinated action across multiple genetic networks.

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.